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Summary 
The contribution of antigen-driven B cell adaptive immune responses within the inflamed 
muscle of inflammatory myopathies is largely unknown.  In this study we investigated the 
immunoglobulin VH gene repertoire, somatic hypermutation, clonal diversification, and 
selection of infiltrating B cells in muscle biopsies from inflammatory myopathy patients 
(dermatomyositis and polymyositis), to determine whether B cells and/or plasma cells  
contribute to the associated pathologies of these diseases.  The data reveal that Ig VH gene 
repertoires of muscle-infiltrating B cells deviate from the normal VH gene repertoire in 
individual patients, and differ between different types of inflammatory myopathies. Analysis of 
somatic mutations revealed clonal diversification of muscle-infiltrating B cells and evidence for 
a chronic B cell response within the inflamed muscle. We conclude that muscle-infiltrating B 
cells undergo selection, somatic hypermutation and clonal diversification in situ during antigen-
driven immune responses in patients with inflammatory myopathies, providing insight into the 
contribution of B cells to the pathological mechanisms of these disorders.  
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Introduction 
Inflammatory myopathies (IMs) are a group of autoimmune diseases, associated with 
inflammatory cell infiltration to the muscle and muscle weakness; this can vary from mild to 
severe or, in some cases, absence of muscle weakness (amyopathic DM). IMs are composed of 
three principal subsets: dermatomyositis (DM), polymyositis (PM) and inclusion body myositis 
(IBM), each with distinct clinical and pathological features.  In DM, inflammation is 
predominately perivascular and/or perimysial around the muscle fascicles [1;2] with  
infiltrations consisting largely of B cells and CD4
+
 T cells, indicating a humoral immune 
response [3;4].  PM & IBM are characterised by scattered necrotic and regenerating muscle 
fibres and endomysial inflammation with invasion and destruction of non-necrotic muscle fibres 
[1;2].  Inflammatory infiltrates in both disorders mostly consist of CD8
+
 T cells and 
macrophages [3;4] which invade MHC class I antigen expressing muscle fibres [5] leading to 
fibre necrosis.  In contrast to DM, B cells are few or absent within the inflammatory infiltrates 
of PM and IBM. However, various autoantibodies are associated with DM and PM, and in some 
cases IBM [6-8], suggesting that a loss of B cell tolerance may contribute to disease 
pathogenesis in all IMs. 
 
Generation of B cells expressing high affinity antibodies classically occurs within germinal 
centres (GCs) in secondary lymphoid organs, where they are induced to proliferate and undergo 
affinity maturation through the process of somatic hypermutation (SHM), further diversifying 
their Ig repertoire and generating clonally expanded cells.  Selection of cells with the highest-
affinity receptors leads to the formation of memory B cells and plasma cells, reviewed in [9].  
Such GC-type reactions with biased Ig V-gene repertoires of the infiltrating B cells have also 
been found in the target tissues of various autoimmune and inflammatory disorders [10;11].   
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The contribution of ectopic GC-type reactions within inflamed muscle of the IMs is still largely 
unknown.  We propose that B cells infiltrating the muscle tissues of myositis patients are 
actively proliferating in response to antigen in situ with SHM and affinity selection of their 
antibody receptors, resulting in aberrant Ig V-gene repertoires.  An antigen-driven B cell 
response bears the signature of clones of B cells expressing clonally related sets of rearranged Ig 
V-genes. The members of each B cell clone use the same germline VH-gene with the same V-D-
J junctional sequences and both shared and unshared somatic mutations with selection for 
replacement mutations, especially in the complementarity determining regions (CDRs) [11].  
We have investigated this by identifying muscle-infiltrating B cells and plasma cells, examining 
selection for their expressed Ig V-genes, analysing selection for replacement mutations, and by 
comprehensive analysis of their clonally-related Ig V-gene sequences using IgTree© [12].  The 
results clearly emphasise the role of B cells within IM disorders.         
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Results 
Identification of muscle-infiltrating B cells in inflammatory myopathies 
B cells (CD20
+
) and plasma cells were identified in the inflamed muscle of 12 from 17 myositis 
patients (2/4 DM, 9/11 PM and 1/2 IBM) and absent in the normal control muscle ((Supporting 
Information Table 1) (Figure 1A & C), also briefly reported in [11]).  Muscle-infiltrating B cells 
were present in loose to dense cellular aggregations in the appropriate perivascular/perimysial 
or endomysial locations corresponding with the myositis subset but no classical GC structures 
were observed.  The largest infiltration of CD20
+
 B cells was observed in the muscle samples 
from DM patients, with low numbers in the PM and IBM samples; each sample contained 
significant numbers of plasma cells.  FDCs were rare in all samples, and were only observed in 
small proportions in 3 PM patients and the 1 IBM patient (Figure 1B).  CD3
+
, CD4
+
 and CD8
+
 
cells were mostly found to mirror previous observations [3;4] (not shown).  No non-specific 
staining was observed with isotype controls. 
 
Proliferating (Ki67
+
) cells were also observed in a number of samples (Figure 1D); double 
immunofluorescent staining revealed proliferating CD20
+
 B cells (Figure 1E and [11]), as well 
as CD4
+
 and CD8
+
 cells (not shown). 
 
Ig V-gene repertoires of muscle-infiltrating B cells in DM and PM differ from control 
repertoires 
148 independent rearranged Ig V-genes from micro-dissected populations of muscle-infiltrating 
cells (93-DM; 55-PM) were amplified and sequenced to determine whether there is selection for 
specific Ig VH, D and JH exons.  Ig V-gene repertoires were established for each patient (2 DM 
and 9 PM) followed by a pooled analysis from patients in each myositis DM/PM subset.  The 
results suggest selection of particular Ig V-genes in both a patient-specific and, in some 
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instances, disease-specific manner relative to the normal peripheral blood (PB) B cell [13] and 
germline repertoires (Figure 2A-C).  Over 600 sequences were initially analysed; following the 
removal of duplicate sequences (with the same VH, D, JH, CDR3 sequence and point mutations) 
and those which gave unreadable sequence readouts. Some of these results have been briefly 
described elsewhere [11].  Most of the significant deviations from the normal VH gene 
repertoire were observed in DM patients (Figure 2A).  Reductions in the use of VH1 and VH4 
gene segments and increases in the use of VH2 gene segments were observed compared with 
control PB B cell repertoires, while the use of VH3 gene segments was significantly increased in 
the pooled DM repertoire compared with both the germline and control PB B cell repertoires.  
Over-representation of VH3 gene segments was also observed in each of the individual DM 
patients, and in one PM patient (M23). In contrast, the pooled PM patient repertoire revealed 
increased use of VH5 gene segments compared with DM. Analysis of individual PM patients 
suggested selection for and against particular gene segments in a patient-specific manner.  
Patient M3 showed significant over-representation of VH1 gene segments, while patient M5 
showed significant reduction of VH1 usage in favour of VH5, compared with that of control 
repertoires.  Significant differences from normal PB B cell repertoires were also observed in the 
D and JH exons (Figure 2B & C).  Representation of the D6 gene segments was increased in DM 
patients, while that of JH1 was decreased.  In PM patients, the use of JH2 and JH5 exons was 
increased when compared with the control PB B cell repertoire.  Significant differences between 
DM and PM subsets were also observed in the use of JH2, JH5 and JH6 exons.  The use of 
individual exons within each family was studied (not shown).  DM patients had a preference for 
VH3-11, VH3-15, VH3-30 and VH3-9, and against VH4-34, whereas PM patients had increased 
frequencies of VH3-30 and VH5-51 gene segments in muscle-infiltrating B cells.  Despite 
numerous attempts, only two different rearranged V-gene sequences were isolated from the 
IBM sample, therefore these were not included in the statistical analysis.  
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Abundant hypermutation in Ig V-genes expressed by muscle-infiltrating B cells in DM and 
PM patients 
To examine SHM and clonal expansion within the muscle infiltrating repertoire, the numbers, 
locations and distributions of single-point mutations in each rearranged gene were established 
and are presented as pooled data according to the myositis DM/PM subset (Figures 2D and 2E).   
The frequency of mutations suggests infiltration of distinctive subsets of B cells into inflamed 
muscle in DM and PM patients (Figure 2D).  In DM patients, almost 50% of sequences 
contained 0-2 mutations in the VH region, suggesting that there is a large population of naïve 
cells in this subset compared with that in PM patients, where the majority of cells contained a 
large number of mutations.   
 
As expected, the majority of single point mutations were found within the CDRs (Figure 2E) 
and the percentage of mutations within CDR1 was similar for DM and PM patients, whereas 
CDR2 in PM was more heavily mutated.  Due to difficulties in ascertaining mutations within 
CDR3, mutational analysis was not conducted for this part of the gene. 
 
Clonal expansion of muscle-infiltrating B cells in inflammatory myopathies  
Lineage trees, demonstrating clonal expansion of the infiltrating B cells in situ, were 
constructed from the 38 clonally-related Ig V-gene sequences isolated from 2 DM and 3 PM 
patients (with the exception of one clone from patient M1) using IgTree© [12] (Figures 3A-C), 
with the gene features of all clones summarised in Supporting Information Table 2.  M16 clones 
A & B represent B cell clonal expansions isolated from different cellular aggregations from the 
same tissue section.  There was no evidence to suggest the migration of clones between 
different cellular aggregations, suggesting that the clones were generated independently and 
maintained within each cell cluster.  
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As controls, we used lineage trees of 10 control clones from GCs in normal spleens and Peyer's 
patches [14], as there are no B cells in normal muscles, and lineage trees and single sequences 
which are not clonally-related from PB B cells of healthy controls.  All but one (M16 clone B) 
of the myositis lineage trees had long trunks and were less branched compared to the normal 
GC and PB trees. The long trunks imply that the founder cells are either memory B cells which 
were activated elsewhere, or that the disease has been ongoing for a long period of time.  
 
In addition to the qualitative assessments, lineage trees from myositis patients were also 
quantitatively measured to evaluate the extent of clonal diversification, mutation and antigen-
driven selection in comparison to normal GC and PB trees (Figure 3D).  Lineage tree properties 
demonstrated several significant differences between myositis and normal controls, as follows. 
The myositis trees had significantly longer minimal root-to-leaf paths (PL-min) and root-to-fork 
distances (DRSN-min) compared to both groups of normal control trees, due to the significantly 
longer trunk lengths.  These results suggest that the response has been ongoing for a long time, 
as befits a chronic inflammatory reaction which included the observed B cell clones. In 
addition, the myositis clones had a significantly lower average outgoing degree (OD-avg, i.e., 
the average number of children per node) compared with that of the normal controls.  This may 
imply, according to correlations with B cell response dynamic parameters [15], a higher 
mutation rate in the myositis clones, compared with that of the normal controls.  However, this 
interpretation should be taken with caution, as the differences observed in OD may also be due 
to a lower sampling size in the myositis data group. 
 
Comprehensive Ig V-gene mutational analyses show deviations from normal responses 
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To further enhance our understanding of the antigen-driven SHM and affinity maturation 
processes ongoing within the muscle, several types of mutational analyses were performed on 
the myositis and control sequences.  All were performed per-tree, and thus avoid mutation over-
counting.  We first examined the SHM spectrum in myositis in comparison with normal GC and 
PB sequences (Figure 4).  The mutation spectra seen in the myositis sequences were 
significantly different from those of the PB normal control sequences (Figure 4A).  A/T 
nucleotides were mutated with lower frequencies than those of C/G nucleotides, and the 
frequencies of mutations from A and T were similar, in contrast to the normally observed 
mutation bias from A nucleotides.  C/G nucleotides were also mutated with the same frequency, 
similarly to what is normally observed.  The myositis sequences also exhibited a slight 
transversion bias, which was significantly different from the transition bias observed in both 
normal controls (Figure 4B) and in additional studies [16;17].  In mutations from A/T, the 
myositis targeting motifs were similar to those of the normal controls and the motifs reported in 
the literature.  However, in mutations from C/G, the myositis sequences failed to show the 
normal targeting motifs in position +1 in mutations from C and in positions -1 and +2 in 
mutations from G.  In addition, the different motifs around C/G mutations did not exhibit 
reverse complementarity, implying that the activation-induced cytidine deaminase (AID) 
machinery does not act equally on both strands in this case (Figure 4C).  There may be several 
reasons for these deviations, as discussed below.  
 
Next, we analysed R and S mutations within the FWR and CDRs of the clonally-related 
myositis sequences, comparing the myositis clones with normal GC and PB clones as 
constructed by IgTree© [12].  In the FWRs, the myositis and normal control groups showed 
significant positive selection for R mutations (P=0.03 and 2x10
-7
, respectively).  However, most 
of these mutations were either conservative or neutral, as demonstrated by the amino acid (aa) 
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substitution analysis (see below).  Thus these results indicate that there is no real selective drive 
towards a change in the FWR structure in the clonally-related sequences.  In the CDRs the 
myositis group showed a weak (not significant) positive selection for R mutations, as expected 
if these clones, at the time of observation, were still undergoing affinity maturation and 
selection for the Ag. 
 
Finally, aa substitutions were enumerated for the myositis and the normal control groups.  Each 
mutation was enumerated in the FWRs and CDRs separately (Figure 5).  The average frequency 
of aa substitutions in the myositis group ("all regions", referring to the combined CDRs and 
FWRs) was significantly higher than that of the normal GC (P-value = 0.013) and significantly 
lower than that of the normal PB (P-value = 4.63E-10) groups, due to the different number of 
mutations in each group.  Most R mutations in all data groups were found in the FWRs (>70% 
in all groups, out of total R mutations) rather than CDRs.  However, most of these were either 
conservative or neutral (17%, 80% and 83% in the myositis, normal GC and normal PB 
respectively, out of the total R mutations in the FWRs).  Indeed, it was shown [18] that Ig V-
genes have evolved in such a way that FWR codon usage is biased to result in a minimum of 
non-conservative aa replacements.  In addition, most mutations were clustered around the 
diagonal, showing a conservation of hydrophobicity, which is important for conservation of 
protein structure, as expected in the FWRs.  
 
Identification of antigen-specific muscle-infiltrating B cells in inflammatory myopathies    
The identification of antigen-specific cells was briefly explored towards the conclusion of this 
study, to elucidate the identity of antigen(s) as potential candidates for stimulating the response. 
Antigen-specific cells were initially identified using light microscopy (not shown) with antigen-
specific B cells and plasma cells identified using double immunofluorescence microscopy on 
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biopsies from 5 patients whose sera contained antibodies against Jo-1 (a myositis-specific antigen), 
nuclear antigens Sm/RNP, Scl-70 and DNA, singly or in combination with another antigen. Both 
antigen-specific B cells and plasma cells were observed within the infiltrating cell populations 
(Supporting Information Fig.1), although there was only a limited number of antigen-specific cells 
in relation to the total number of infiltrating B cells and plasma cells, suggesting that alternate or 
modified versions of antigens may also be responsible for stimulating the B cell response within 
IMs. The phenotype of antigen-specific cells (B cell or plasma cell) was uniform throughout the 
sections, with the exception of one sample with specificity towards Scl-70. Jo-1 specific B cells and 
plasma cells have been described briefly elsewhere [110]. Antigen-specific cells were isolated using 
laser capture micro-dissection followed by single cell V-gene amplification or amplification of V-
genes from a small number of cells with the same antigen-specificity. Within the constraints of the 
study only a limited number of sequences were isolated and sequenced; therefore, no definitive 
conclusions can be drawn concerning the V-gene repertoire and mutation patterns used by 
autoantigen-specific cells.  
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Discussion 
Of paramount importance in the understanding of autoimmune inflammatory disorders is 
whether highly specific, antigen-driven adaptive immune B cell responses occur within the 
target tissues.  We have addressed the hypothesis that B cells infiltrating the muscle tissues of 
myositis patients are actively proliferating in response to antigen in situ, resulting in Ig V-gene 
repertoires deviating from normal control values [13], with SHM and affinity selection of their 
antibody receptors.  The work presented here supports this hypothesis; oligoclonal expansion of 
B cells was observed; analysis of Ig V-gene repertoire and mutational patterns suggest selection 
for particular Ig V-genes and an antigen-driven response.  Taken together, these results indicate 
that antigen-driven, B cell responses occur within the target tissues of myositis patients, and 
provide evidence that B cells play an active and significant role in pathogenesis at the sites of 
inflammation of these diseases, despite the absence of ectopic GC architecture within the target 
tissue.  
 
Our study supports previous observations of inflammatory infiltrates in different myositis 
subsets [3;4;19;20] and demonstrates the active participation of plasma cells and proliferating B 
cells.  In addition, the identification of an abundance of Ig transcripts in IBM and PM patients 
and other studies demonstrating B cell maturation in situ [20-24] implicate a significant role for 
these antibody-secreting cells in immune responses in the inflamed muscle.  Unlike our and 
other groups’ studies of infiltrating lymphocytes within the target tissues of other autoimmune 
disorders [10;11], no characteristic GC structures were observed within the inflamed muscle 
tissue, similar to other studies of IMs [3;4;20-22].  Although FDCs are expected to be present in 
ectopic GCs for antigen presentation and activation of high affinity B cells, FDCs were 
observed in only 4 of the 12 myositis patients diagnosed with PM or IBM, and none in DM 
where B cells are traditionally thought to play a greater role, as also observed in a recent study 
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of IMs [22].  The evidence of antigen-driven reactions suggests that additional cell types 
substitute for the antigen presenting role of FDCs in muscle inflammatory reactions, or that 
these interactions occur elsewhere.   
 
We have identified both patient-specific and, in the case of VH5, JH2, JH5 & JH6 gene segments, 
disease-specific selection for particular rearranged Ig V-gene families.  Affinity maturation of 
muscle-infiltrating B cells was supported by identification of selection for replacement 
mutations in clonally-related sequences from myositis patients compared with normal controls.  
Taken together, our comprehensive lineage tree and mutation analyses provide evidence for 
vigorous B cell antigen receptor diversification in myositis patients, with antigen-driven 
selection acting to change the CDRs, as expected in normal immune responses.  However, the 
mutation spectra differed in several aspects from those observed in controls.  The SHM 
mechanism may be over-exhausted due to chronic activation, as was also suggested by the 
higher mutation rates (according to OD-avg) found in the myositis clones, and thus may be 
responsible for the altered mutation spectra and targeting motifs.  Alternatively, different micro-
environmental signals may lead to subtle differences in the expression of the enzymes that 
participate in SHM, as suggested in our previous study [17].  Indeed, the myositis lineage trees 
had long trunks, suggesting either that they started diversifying elsewhere and continued 
diversifying in the inflamed muscle, or that the diversification observed here started in the 
muscle long before the biopsies were taken, such that only its latest stages are observed.  
Alternatively this could indicate re-stimulation of infiltrating memory B cells.  Overall, these 
results imply a chronic inflammatory reaction of the infiltrating B cells in inflamed muscle from 
myositis patients. 
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Bradshaw et al. [21] recently demonstrated antigen-specific B cell responses occurring in 
muscle of IM patients. In contrast to our study, very few CD19
+
 or CD20
+
 cells were observed, 
with the majority of B-derived cells being CD138
+
 plasma cells which had class switched to 
either IgG or IgA.  Salajegheh et al. [22] also isolated plasma cell Ig sequences derived from a 
common B cell precursor and demonstrated increased gene expression of B cell activating factor 
(BAFF), a cytokine crucial for B cell maturation and survival; all occurring outside the confines 
of ectopic GC structures.  This study confirms and extends this earlier work [21;22], and 
strongly suggests the participation of antigen-specific B cell immune responses in the 
inflammatory response within the muscle.  In parallel with other autoimmune diseases, we 
observed a bias in the Ig VH, D & JH gene repertoires along with the identification of VH-gene 
segments which were clonally expanded in immune reactions within the target tissues, 
providing insights into the usage of preferred VH gene families, clonal expansion of B cells, loss 
of B cell tolerance and gene dysregulation in response to antigen.  Alterations in mutation 
spectra and targeting motifs observed in myositis sequences in this study were also observed in 
our previous study of the ectopic GC response in SS patients [16].  However, whereas studies in 
other autoimmune diseases demonstrated ongoing B cell responses within the context of ectopic 
GCs (reviewed in [11]), we observed the hallmarks of antigen-driven B cell responses in situ in 
the absence of histologically identifiable GCs in the IMs, and deviations in the mutation spectra 
and targeting motifs.  Autoantigen-specific B cells and plasma cells have been identified in and 
around ectopic GCs in MG [25], SS [26;27], and RA patients [28]; we also identified 
autoantigen-specific B cells within the muscle-infiltrating cell population, despite the absence of 
ectopic GC architecture.  Extrafollicular B cell responses with functionally active AID 
expression have been identified in autoimmune target tissues [28].  Identification of clonally 
related sets of Ig V-genes in the absence of GCs demonstrates that antigen-driven B cell 
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responses also take place in the myopathies and not solely within the periphery prior to 
infiltration into the muscle tissues. 
 
Mutation analysis of clonally-related sequences revealed significant differences between 
myositis and normal control sequences.  The spectrum and targeting motifs of nucleotide 
substitutions is largely dependent on the enzymes and pathways that repair the U:G lesions 
created by AID.  The lower number of mutations from A/T nucleotides compared to C/G 
nucleotides observed in the myositis data may result from a deficiency in the low fidelity 
polymerase-eta, which is the main contributor to mutations from A/T nucleotides [29-33].  
Polymerase-eta deficient mice gain the ADK/MHT motif (where D = A/G/T; H = A/C/T; K = 
G/T; M = A/C) [29], also found in our myositis group and in paucity in both controls, especially 
in mutations from T, where C was in excess in position -1 and -2.  The myositis sequences also 
demonstrated a transversion bias.  Polymerase-eta has been shown to favour transition 
mutations [29], and thus its absence or malfunction may lead to fewer transition mutations.  
Previous studies have shown that polymerase-kappa, a low fidelity polymerase with a bias 
toward transversion mutations, is recruited in the absence of polymerase-eta.  The myositis 
sequences also failed to show the normal targeting motifs in mutations from C/G in several 
positions, which may indicate additional defects in the first phase of the SHM mechanism, 
which is responsible for mutations from C/G nucleotides. Indeed, disruptions in the activity of 
uracil DNA glycosylase (UNG), which is responsible for the excision of the U incorporated by 
AID, were previously shown to block transversion mutations from C/G nucleotides [29].  
Recently, UNG has been found to be upregulated in MG patients [34;35], and a transversion 
bias was demonstrated in patients with MG [17], similar to the findings in the myositis 
sequences.   These results may reflect the ectopic microenvironment in which these B cells 
undergo SHM; the lack of regulation outside GCs [36] may induce different types or quantities 
16 
 
of signals in the mutating B cells.  These signals may activate different enzymes and pathways, 
which, in turn, may contribute to deviation of the mutation spectra and targeting motifs from 
what is normally observed.  Alternatively, the altered spectra may result from over-exhaustion 
of the SHM mechanism, possibly caused by the chronic nature of the response. 
 
The significance of B cells in autoimmune diseases, and the potential of these cells as 
therapeutic targets, is further substantiated by B cell depletion therapies, which have emerged as 
influential therapeutic strategies for several autoimmune disorders, including  myositis [37-41]. 
 
To conclude, we confirmed the hypothesis that antigen-driven B cell responses occur within the 
target tissues of myositis patients, and demonstrated deviations in the Ig V-gene repertoire from 
normal control values. Comprehensive mutational analysis revealed that antigen-driven SHM 
and clonal diversification of B cells is taking place within the muscle tissues.  The responding B 
cells are proliferating and mutating outside the confines of ectopic GC structures commonly 
found in the target tissues of autoimmune disorders.  To understand these intramuscular, 
antigen-specific, B cell reactions more fully, future studies need to address the nature of the 
stimulating antigen(s), the specificity and pathogenicity of the secreted antibodies and to 
establish the pathological mechanisms of these antibodies within the myopathies, leading to 
new and improved therapies for these diseases.   
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Materials and methods 
Patients and samples 
Archival muscle biopsies were obtained from the Pathology Department, Western Infirmary, 
Glasgow after informed consent, with approval of the area Research Ethics Committee 
(Supporting Information Table 1).  Biopsies were embedded in OCT and either stored in liquid 
nitrogen or at -70°C.  Serial frozen sections (8 µm) were cut and mounted on positively charged 
slides (VWR, UK), air dried, fixed in acetone for 10 minutes and stored at -70°C. 
 
Immunohistochemical staining of tissue sections 
Serial frozen sections were stained for cellular infiltrates at intervals of 40 – 80 μm, as 
previously described [25], using mouse monoclonal antibodies to CD20 (1:50), CD3 (1:100), 
CD4 (1:10), CD8 (1:50), Follicular Dendritic cell (FDC) clone CNA.42 (1:100), plasma cell 
(1:200) clone VS38c and Ki67 (1:100) (Dako)  as well as control isotype antibodies.   
 
Double immunofluorescence staining for identification of proliferating cells 
Double immunofluorescent staining on frozen serial sections was conducted using the Mouse on 
Mouse (M.O.M) Immunodetection Immunofluorescent Kit (Vector Laboratories, Burlingame, 
CA, USA), according to the manufacturer's instructions.  For identification of proliferating cells 
frozen sections were stained for CD20 (1:100), CD3 (1:100), CD4 (1:50), CD8 (1:100) and 
Ki67 (1:100) (Dako) using mouse monoclonal antibodies as well as control isotype antibodies.  
Sections were mounted in VECTASHIELD hardset mounting medium (Vector Laboratories) 
and immunofluorescence was visualised using a Zeiss Axiovert microscope with a Zeiss Plan-
NEOFLUAR 63x lens (Carl Zeiss Ltd., Welwyn Garden City, UK) and a digital CCD camera 
(Hamamatsu, Tokyo, Japan) with Openlab Deconvolution software (Improvision).  For each 
view, 5 images were taken at 0.5 micron intervals. 
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Double immunofluorescence staining of antigen-specific cells 
Identification and phenotyping of antigen-specific cells was performed as described aboveusing 
2 μg/ml biotinylated recombinant proteins, including Jo-1 (A kind gift from Prof. Paul Plotz, 
NIH, Bethesda, MD, USA); Calf thymus DNA (Sigma); Sm/RNP & Scl-70 (The Binding Site, 
UK), with either a mouse monoclonal antibody to CD20 (1:100) or to plasma cells (1:100) 
(Dako). 
 
Micro-dissection and DNA extraction 
To establish the antibody repertoire, areas containing B cell and plasma cell aggregations were 
micro-dissected using sterile blood lancets under a Nikon Diaphot inverted microscope 
(Melville, NY), and DNA was released by proteinase K digestion using QIAGEN DNA Micro 
Kit (QIAGEN, Sussex, UK), according to the manufacturer's instructions.  The DNA 
preparation was used as a template for subsequent primary PCR reactions. 
 
Amplification, cloning and sequencing of rearranged immunoglobulin VH genes 
Immunoglobulin genes from infiltrating plasma and B cells were amplified using a nested PCR 
system as previously described [25].  All amplification reactions were prepared in a 
Captair™Bio Biocap™RNA/DNA hood (Erlab, France) and were conducted on a T-
professional Thermocycler (Biometra, Tampa, FL) using the Expand High Fidelity PCR System 
with 2.6U DNA polymerase (Roche, Mannheim, Germany).  For primary amplification 
reactions, 10 pmole of VH leader primer mixture and 10 pmole of universal JH primer were used 
with an annealing temperature of 50°C.  Amplified DNA bands, approximately 400 base pairs, 
were excised using QIAquick gel extraction columns (QIAGEN, Sussex, UK) according to  the 
manufacturer's instructions then ligated with TA cloning vector PcRII and transformed into 
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TOP10F’ cells (Invitrogen) and cloned.  Plasmid DNA was prepared using QIAprep mini-prep 
kits (QIAGEN, Sussex, UK) according to the manufacturer's instructions and sequenced.  DNA 
sequencing was performed by The Sequencing Service (School of Life Sciences, University of 
Dundee, Scotland, www.dnaseq.co.uk) using Applied Biosystems Big-Dye Ver 3.1 chemistry 
on an Applied Biosystems model 3730 automated capillary DNA sequencer.  
 
Repertoire of rearranged VH genes expressed on muscle infiltrating B cells from DM and 
PM patients 
To establish the Ig V-gene repertoire and SHM characteristics of the muscle infiltrating plasma 
and B cells, and to identify clonally related sets of sequences, sequences were analysed using 
Chromas Lite software and the best matching corresponding human germline genes were 
identified by searching the IMGT database using JOINSOLVER 
(http://joinsolver.niams.nih.gov) and IMGT/V-QUEST software (http://imgt.cines.fr) [42;43].  
The full repertoire of Ig genes expressed on muscle infiltrating B cells and/or plasma cells was 
established for each patient; data were then pooled and presented according to the myositis 
subset (DM/PM).  In order to assign the best matching D gene segment with 95% probability, 
methods were conducted as described [43].  D genes were statistically assigned with 95% 
probability in 59% and 42% of DM and PM repertoires respectively.  Clonally related 
sequences were identified on the basis of identical VDJ gene rearrangements, CDR3 regions 
and junctional sequences and the number of base changes regarded as significant was based on 
the PCR error rate for the polymerase, previously determined, to be less than one base per 4 VH 
gene segments [25].      
 
Comprehensive mutation analysis of clonally-related Ig V-genes from muscle infiltrating B 
cells 
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Mutations in clonally-related sets of V-genes identified from DM and PM patients (analysed 
collectively as myositis patients) and GC controls were enumerated and analysed in further 
detail using IgTree© [12] and additional programs incorporated into IgTree© [16;17;44;45] that 
perform analysis of mutation targeting motifs, aa replacements and RS analyses utilizing the 
focused binomial test of Hershberg et al. [46].  Thus, the results are subject to the tree structure 
created by the IgTree© program, as previously described [16;17;44;45]. 
 
Statistical analysis 
The distribution of VH, D and JH family usage in each myositis subset, as well as individual VH, 
D and JH gene usage, was compared to normal control values described elsewhere [13] and 
assessed using χ2 analysis using GraphPad Prism (GraphPad Software Inc., San Diego CA, 
USA), P values < 0.05 were deemed significant.  Statistical analysis for the comprehensive 
mutational analysis of clonally related Ig V-genes was conducted as previously described 
[12;16;17;44;45].     
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Figure Legends 
Figure 1. B cells and plasma cells are components of the muscle-infiltrating inflammatory 
population 
Representative examples of serial sections of inflamed muscle tissue from IM patients stained 
for (A) CD20
+
 B cells, (B) follicular dendritic cells (FDCs), (C) plasma cells (clone VS38c) and 
(D) proliferating Ki67
+
 cells visualised using APAAP labelling (red) and haematoxylin (light 
blue), except Ki67 sections which were not stained with haematoxylin as both constitute nuclear 
stains.  (E) Double immunohistochemical staining was performed for CD20, visualised by 
Fluorescein Avidin D (green), and Ki67, visualised by Texas Red Avidin D (red) to identify 
proliferating B cells within the infiltrating cell population.  (A, B & D) Images were taken from 
samples from 2 DM patients (M16 (A, B); M1 (D)). (C, E) Images were taken from samples 
from PM patients (M5 and ME respectively).  (C) Black arrows indicate the presence of plasma 
cells; (E) white arrows indicate Ki67
+
, CD20
+
 proliferating B cells.  Initially sections at 
intervals of between 40 to 80 μm were stained for CD20+ B cells and plasma cells to determine 
the presences of these phenotypes (n=3-7 depending on the tissue availability).  Serial sections 
surrounding areas of B cell and/or plasma cell infiltration were used to establish the infiltration 
of the other cell phenotypes (n≥3).  Original objective lens magnification for images A-D: 40x; 
E: 63x.  (E) Scale bar is 15 µm.   
 
Figure 2 
Diverse V-gene family usage and abundant somatic mutations in muscle-infiltrating B 
cells and plasma cells in DM and PM patients 
Comparison of (A) VH, (B) D and (C) JH gene family usage in functionally rearranged V-genes 
expressed by muscle-infiltrating B cells and plasma cells in DM and PM patients.  DNA was 
released from micro-dissections (n≥3 from different cellular aggregations within the same 
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section and/or different sections) and amplified using a nested PCR system.  Best matching 
germline genes were identified from aligning sequences in the IMGT database using 
JOINSOLVER software [43].  Gene distributions were compared, from 148 independent 
sequences (DM-93; PM-55) to expected values based on the germline complexity and published 
normal PBL control gene distributions [13].  * Represents a significant difference from the 
germline composition; ** represents a significant difference from normal control values, † 
represents a significant difference between DM and PM myositis subsets (p<0.05, χ2 test).  (D) 
The number of single point somatic mutations in V-gene regions was identified by comparison 
with the closest matching germline VH gene.  The first 24 nucleotides of the genes were 
excluded from the analysis as they were encoded by the 5’ VH primer.  (E) The locations of 
mutations observed within functionally rearranged genes were categorised as being within FWR 
or CDR regions.  The number of mutations within these regions was expressed as a percentage 
of the entire length of the region, to correct for the longer lengths observed within the FWR.   
 
Figure 3 
Oligoclonal expansion of muscle-infiltrating B cells and plasma cells in DM and PM 
patients 
Lineage trees were constructed from sequences isolated from muscle-infiltrating B cells and 
plasma cells in individual patients using the IgTree© [12]; sample drawings of lineage trees 
from (A) myositis patients, (B) normal control spleen and Peyer's Patch GCs (data included 19 
clones from 5 patients [14]) and (C) normal control PB (data included 33 clones from 3 patients, 
[47]) are shown.  The double circles represent the germline gene, empty circles are hypothetical 
split node intermediates and black circles are the observed sequences.  The numbers by each 
edge represent the number of mutations that separate the corresponding nodes.  Edges that are 
not accompanied by a number represent one mutation. (D) Comparison of lineage tree 
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properties between myositis patients and normal GC and PB controls.  Data are shown as the 
mean and SD calculated on the PL-min, DLFSN-avg, DRSN-min, T, OD-avg, RootD and 
DASN-min measurements of the trees.  There were 8 myositis (pooled DM and PM) trees, 19 
normal GC trees, and 33 normal PB trees.  Each tree represents one clone.  PL-min: minimum 
path length; DLFSN-avg: average trunkless path; DRSN-min: minimum root-fork distance; T: 
trunk; OD-avg: average outgoing degree; RootD: minimum root-fork distance; DASN-min: 
minimum fork-fork distance.  Statistical significance was determined by the Mann–Whitney U-
test and the FDR correction for multiple comparisons.  
 
Figure 4 
SHM spectrum and targeting motifs of clonally-related sequences from myositis patients 
differ from those of controls. (A) Mutation frequencies.  The number of mutations from each 
nucleotide, presented as percentage out of the total number of mutations.  The numbers above 
each circle represent the total number of mutations analysed in each group.  (B) Transition 
(white) versus transversion (black) mutations, presented as percentage of the total number of 
mutations.  (C) SHM targeting motifs.  Nucleotides flanking the mutated nucleotide in six 
positions were enumerated for each type of mutation.  On the X-axis, −1, −2 and −3 denote the 
three positions flanking the mutation upstream; +1, +2 and +3 denote the three positions 
flanking the mutation downstream.  Letters on the positive and negative sides of the Y-axis 
denote excess or paucity of the indicated nucleotide in that position, respectively.  The size of 
each letter is proportional to the “% difference”, that is, the percentage composition of each base 
at each position flanking a p articular mutation, minus the baseline percentage composition of 
the germline sequences, to show any differences particular to that mutation.  The levels of 
significance of the frequency of the mutated nucleotide compared with its theoretical frequency 
(χ2 test) are indicated by asterisks: *p<0.05, **p<0.005 and ***p<0.0005.  Motifs were 
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compared with normal targeting motifs reported in the literature [48-53], as shown at the bottom 
in the line marked “Reported motifs”; the mutated nucleotides are depicted in colour.  
 
Figure 5 
AA substitutions in sequences from myositis patients mostly maintain the receptor's 
structure. Enumeration of aa substitutions for myositis and normal GC and PB sequences.  The 
rows (indicated on the left) represent the pre-mutation aa and the columns (indicated on the top) 
represent the post-mutation aa.  The coloured squares represent the average frequency of a 
mutation in all trees in a data group – the unscaled frequencies for "all regions" and scaled by 
region lengths (in parentheses) for the FWRs/CDRs are given in the key.  The coloured circles 
represent the nature of aa substitutions – conservative, neutral or altering. 
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Supplementary Table 1  
Clinical Characteristics of IM Patients 
 
Subject Diagnosis 
Age at 
biopsy/Gender 
Disease Duration 
from Diagnosis 
CK (IU/L)  
Therapies at time 
of biopsy  
M1    DM a) 40/F 0 142 - 
M16 DM 33/F 0 1076 - 
      
M3 PM 80/M 0 897 NSAID 
M5 PM 40/F 3.5 years 1031 Pred, IVIg 
M6 PM 63/M 0 919 - 
M7 PM 50/M 0 8390 - 
M19 PM 62/F 0 Normal 
MTX, 
Corticosteroid 
M23 PM 45/F 0 5829 - 
M24 PM 59/F 0 6623 Pred, Statins  
MC PM 66/M 0 2500 Pred, Statins 
ME PM 49/F 0 NR Pred  
      
M17 IBM 66/F 0 2716 - 
      
Control N/A 37/F N/A NR N/A 
 
a) DM, Dermatomyositis; PM, Polymyositis; IBM, Inclusion Body Myositis; F, Female; M, Male; N/A, Non-
Applicable; NR, No Record; NSAID, Non-Steroidal Anti-Inflammatory Drugs; Pred, Prednisolone; IVIg, 
Intravenous Immunoglobulin; MTX, Methotrexate; CK, Creatine Kinase. 
 
 
 
 
 
 
 
 
Supplementary Table 2  
Sequence Characteristics of Clonally-related Ig V-genes Isolated from Muscle-Infiltrating B cells a) 
 
Patient 
(Diagnosis) 
Clone 
Germline Genes Range of point 
mutations/VH 
region b) 
Number of Observed 
Clonal Variants using 
IgTree© c) 
CDR3 
Length 
(aa) VH D JH 
M1 (DM) A 3-66*01 2-21*01 3*02 26-31 2 19 
M16 (DM) 
A 3-07*01 
No D Gene 
Assignment 
3*02 24-34 9 14 
B 3-11*01 
No D Gene 
Assignment 
6*03 0-13    5  d) 19 
M3 (PM) A 1-46*01 
No D Gene 
Assignment 
5*02 10-11 2 14 
M5 (PM) 
A 3-30*04 5-12*01 6*02 16-19 2 22 
B 3-53*01 3-22*01 4*02 18 2 16 
C 4-34*01 
No D Gene 
Assignment 
4*02 25-28 3 10 
D 5-51*01 
No D Gene 
Assignment 
3*02 12-32 4 18 
M23 (PM) A 3-33*01 
No D Gene 
Assignment 
5*02 8-18     2  e) 14 
 
 
a) Clonally-related sequences were identified based on a common VDJ gene rearrangement, CDR3 and junctional composition.  Best matching germline genes were 
identified by searching the IMGT database using the JOINSOLVER software.  In some cases a D gene could not be assigned with statistical significance according 
to the assignment criteria [43].  
b) A total of 252 mutations were analysed using IgTree©;  
c) The total number of sequences analysed, including replicates, was 38;  
d)  Indicates that the germline gene was also isolated from the myositis B cell infiltrating population;  
e) Two additional genes were also identified which exhibited the same CDR3, VD and DJ junctional sequences and a similar mutational pattern but the VH sequences 
were matched with a higher score to a different gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Results 
Identification of antigen-specific muscle-infiltrating B cells in inflammatory myopathies 
 
The identification of antigen-specific cells was briefly explored towards the conclusion of 
this study, to elucidate the identity of antigen(s) as potential candidates for stimulating the 
response.  Antigen-specific cells were initially identified using light microscopy (not shown) 
with antigen-specific B cells and plasma cells identified using double immunofluorescence 
microscopy on biopsies from 5 patients whose sera contained antibodies against Jo-1 (a 
myositis-specific antigen), nuclear antigens Sm/RNP, Scl-70 and DNA, singly or in 
combination with another antigen.  Both antigen-specific B cells and plasma cells were 
observed within the infiltrating cell populations (Supplementary Figure 1), although there 
was only a limited number of antigen-specific cells in relation to the total number of 
infiltrating B cells and plasma cells, suggesting that alternate or modified versions of antigens 
may also be responsible for stimulating the B cell response within IMs.  The phenotype of 
antigen-specific cells (B cell or plasma cell) was uniform throughout the sections, with the 
exception of one sample with specificity towards Scl-70.  Jo-1 specific B cells and plasma 
cells have been described briefly elsewhere [10].  Antigen-specific cells were isolated using 
laser capture micro-dissection followed by single cell V-gene amplification or amplification 
of V-genes from a small number of cells with the same antigen-specificity.  Within the 
constraints of the study only a limited number of sequences were isolated and sequenced; 
therefore, no definitive conclusions can be drawn concerning the V-gene repertoire and 
mutation patterns used by autoantigen-specific cells.   
 
 
 
Supplementary Figure 1 
 
Representative examples of sections of inflamed muscle from IM patients stained for CD20+ 
B cells and plasma cells and with biotinylated antigens to identify the phenotype of muscle-
infiltrating, antigen-specific cells.  Antigen-specific cells were visualised by Fluorescein 
Avidin D (green) and Texas Red Avidin D (red).  Images were taken at 63x (objective lens); 
Scale bar represents 15 μm.  Arrows identify antigen-specific cells within the muscle-
infiltrating population.  Images shown are from sections surrounding areas of B cell and/or 
plasma cell infiltration, as described for Figure 1, and were used to establish the infiltration 
and phenotype of antigen-specific cells (n≥3). 
 
 
 
 
 
 
Supplementary Methods 
 
Double immunofluorescence staining of antigen-specific cells 
 
Identification and phenotyping of antigen-specific cells was performed as described in 
Materials and Methods using 2 µg/ml biotinylated recombinant proteins, including Jo-1 (A 
kind gift from Prof. Paul Plotz, NIH, Bethesda, MD, USA); Calf thymus DNA (Sigma); 
Sm/RNP & Scl-70 (The Binding Site, UK), with either a mouse monoclonal antibody to 
CD20 (1:100) or to plasma cells (1:100) (Dako).   
 


 Fig. 3. Titre of anti-ErB2 antibodies in sera of immunised animals at 16 weeks. (A) All 15 of the ErbB2-P30 
immunised animals showed high titres of anti-ErbB-2 antibody up to 28 weeks of age, diminishing significantly 
by week 32. (B) The control animals immunised with either wild type insect cell supernatant and adjuphos or 
adjuphos only did not show any ErbB2-P30 specific antibody response when the titre was compared to the IgG 
subclasses of animal immunised with ErbB2-P30. In the latter animals IgG1 was significantly higher compared 
with IgG2a at the age of 16 weeks when the titre was at its highest. 
0 
10 
20 
30 
40 
50 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
%
 o
f 
d
is
tr
ib
u
ti
o
n
 
IgVK Family 
Comparison of VK-gene family expression in ErbB2-specific B-cells with non-
specific B-cells and the germline repertoire 
 
Germline 
ErbB2 Specific 
Non Specific 
0 
10 
20 
30 
40 
50 
60 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
%
 o
f 
d
is
tr
ib
u
ti
o
n
 
IgVH Family 
Comparison of VH-gene family expression in ErbB2-specific B-cells 
with non-specific B-cells and the germline repertoire 
Germline 
ErbB2 Specific 
Non Specific 
 
   A  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
          B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             ██                                                               █ 
              C                                                      D 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Expression of IgVκ and IgVH gene families and somatic hypermutation in anti-ErbB-2 
antibodies.  (A & B) Relative distribution of expression of IgVκ and IgVH families among ErbB-2 
specific compared with non-specific, splenic B cells and the germline repertoire; (C & D) Comparative 
distribution of replacement mutations in IgVH & IgVκ genes expressed by ErbB-2 specific and non-
specific, B cells in ErbB2-P30 immunised mice. There is restricted expression of V-gene families in 
ErbB-2 specific B cells compared with the number of members in germline genes and the non-specific 
repertoire, especially Vκ4, Vκ8 and VH4.  A high level of replacement mutations was observed in both 
VH and Vκ-genes from ErbB-2 specific B cells compared with non-specific cells. 
 
